Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Arruga

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Scientific Reports|September 29, 2025
Genome editing strategies to generate working models of polycystic kidney diseaseMartina Migliorero, Donatella Marsalla, Francesco Edoardo Vallone, et al.
Cancer|August 27, 2004
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubationDaniela Cilloni, Francesca Messa, Enrico Gottardi, et al.
Scientific Reports|October 7, 2023
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemiaCandida Vitale, Valentina Griggio, Maria Todaro, et al.
Leukemia|December 15, 2019
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Plos One|October 16, 2019
HaTSPiL: A modular pipeline for high-throughput sequencing data analysisEdoardo Morandi, Matteo Cereda, Danny Incarnato, et al.
Leukemia|August 31, 2019
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Journal of the National Cancer Institute|January 9, 2018
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic MelanomaValentina Audrito, Antonella Managò, Sofia La Vecchia, et al.
Frontiers in Oncology|December 16, 2020
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical RelevanceGiovanni D'Arena, Vincenzo De Feo, Giuseppe Pietrantuono, et al.
Cancer|January 31, 2006
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cellsAlessandro Morotti, Daniela Cilloni, Francesca Messa, et al.
Haematologica|April 30, 2008
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyDaniela Cilloni, Francesca Messa, Francesca Arruga, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Scientific Reports|September 29, 2025
Genome editing strategies to generate working models of polycystic kidney diseaseMartina Migliorero, Donatella Marsalla, Francesco Edoardo Vallone, et al.
Cancer|August 27, 2004
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubationDaniela Cilloni, Francesca Messa, Enrico Gottardi, et al.
Scientific Reports|October 7, 2023
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemiaCandida Vitale, Valentina Griggio, Maria Todaro, et al.
Leukemia|December 15, 2019
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Plos One|October 16, 2019
HaTSPiL: A modular pipeline for high-throughput sequencing data analysisEdoardo Morandi, Matteo Cereda, Danny Incarnato, et al.
Leukemia|August 31, 2019
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Journal of the National Cancer Institute|January 9, 2018
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic MelanomaValentina Audrito, Antonella Managò, Sofia La Vecchia, et al.
Frontiers in Oncology|December 16, 2020
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical RelevanceGiovanni D'Arena, Vincenzo De Feo, Giuseppe Pietrantuono, et al.
Cancer|January 31, 2006
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cellsAlessandro Morotti, Daniela Cilloni, Francesca Messa, et al.
Haematologica|April 30, 2008
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyDaniela Cilloni, Francesca Messa, Francesca Arruga, et al.
Pageof 5